Merck Expands End-to-End Biodevelopment Capability

Product News   Jan 10, 2017 | Original Story From Merck

 
Merck Expands End-to-End Biodevelopment Capability
 
 
FURTHER INFORMATION
 
 
 

Related Product News

Dolomite Bio Offers Single-Cell RNA-Seq to Tackle Kidney Research

Product News

Scientists in Australia have adopted Dolomite Bio's Single Cell RNA-Seq System to extend their research into animal models of diabetic nephropathy.

READ MORE

Glythera and IONTAS Develop Multiple Antibodies for Next-Generation Antibody Drug Conjugates

Product News

Both companies enter into license agreement to develop antibody drug conjugates for difficult-to-treat cancers.

READ MORE

Irvine Introduces Chemically-Defined Dendritic Cell Culture Medium for Immunotherapy Applications

Product News

Irvine Scientific introduces chemically-defined, animal component-free medium to differentiate monocytes into subsequent maturation in dendritic cells.

READ MORE

Like what you just read? You can find similar content on the communities below.

Biopharma Cell Science Diagnostics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE